Quantcast

Latest Benign prostatic hyperplasia Stories

2014-09-18 08:29:25

Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept. 18, 2014 /PRNewswire/ -- Australian biomarker discovery company Minomic International Ltd will today launch an important US trial of its MiStat(TM) prostate cancer screening test, planning to achieve US Food and Drug Administration (FDA) regulatory approval upon completion. Minomic's proprietary MiStat(TM) technology is a screening assay capable of identifying the presence of a...

2014-09-03 08:27:14

Innovative Urolift procedure for treatment of BPH in men has minimal side effects NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure. http://photos.prnewswire.com/prnvar/20140408/NY00250LOGO According to Dr. Alex...

2014-09-02 23:06:24

According to the European urological device market report by iData Research, over 1.6 million urological procedures will be performed by 2020 in Europe; this includes stone management, interventional BPH and nephrostomy procedures. Vancouver, BC (PRWEB) September 02, 2014 According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the European urological device market is expected to grow to over €2 billion...

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

2014-07-08 23:14:27

HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution agreement through its Endocare, Inc. subsidiary with HS Medical, Inc. that expands HealthTronics’ technology portfolio to include a new, targeted ablation solution. Austin, Texas (PRWEB) July 08, 2014 HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution...

2014-07-02 08:27:35

Testosterone Gel (1%), the Generic Equivalent to Vogelxo(TM) (testosterone) Gel, Expected to Increase Access for Patients Who Need It MAPLE GROVE, Minn., July 2, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA) approved Vogelxo((TM)) (testosterone) gel 1%, for topical use, CIII, and the first and only available generic testosterone replacement therapy (TRT) available in three...

2014-06-19 23:16:34

NCMA’s Santa Rosa Urology and Dr. Michael Lazar provide diagnostics, treatment and management of a full spectrum of urologic health conditions including bladder stones. (PRWEB) June 19, 2014 Bladder stones are exactly what they sound like; hard stone-like pieces of concentrated urine which have crystallized and clumped together. Interestingly enough, in developing nations, bladder stones are fairly common in children – and sadly, as a result of dehydration, infection and a low-protein...

2014-06-09 12:29:27

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Japanese Urological Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/japanese_urological_devices_market.html In 2012, the Japanese market for urological devices was valued at $411.9 million.This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney...

2014-05-30 12:25:59

WASHINGTON, May 30, 2014 /PRNewswire-USNewswire/ -- LUGPA will celebrate June as the start of Men's Health Month, urging men to take control of their health by educating themselves on important health issues. "Studies show that men are more likely to avoid going to the doctor than women, leaving them at the mercy of an unimaginable number of diseases and conditions that could have been prevented or improved if only they had talked to their doctor," said Dr. Juan Reyna, president of...

2014-05-28 20:22:42

Natesto(TM) is the first nasal testosterone replacement therapy approved by FDA TORONTO, May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto(TM) (testosterone), formerly CompleoTRT(TM), the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Natesto(TM) is...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related